Dohyun Im

Dohyun Im

Auto-generated profile, based on publicly available information

Dohyun Im

Department of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
YNYoung-Woo Nam
Young-Woo Nam
DIDohyun Im
Dohyun Im
AGAna Santa Cruz Garcia
Ana Santa Cruz Garcia
MTMarios L. Tringides
Marios L. Tringides
HNHai Minh Nguyen
Hai Minh Nguyen
MZMiao Zhang
Miao Zhang
Small-conductance Ca2+-activated K+ (KCa2.1-KCa2.3) channels modulate neuronal and cardiac excitability. We report cryo-electron microscopy structures of the KCa2.2 channel in complex with calmodulin and Ca2+, alone or bound to two small molecule inhibitors, at 3.18, 3.50, 2.99 and 2.97 angstrom resolution, respectively. Extracellular S3-S4 loops in β-hairpin configuration form an outer canopy over the pore with an aromatic box at the canopy’s center. Each S3-S4 β-hairpin is tethered to the selectivity filter in the neighboring subunit by inter-subunit hydrogen bonds. This hydrogen bond network flips the aromatic residue (Tyr362) in the filter’s GYG signature by 180°, causing the outer selectivity filter to widen and water to enter the filter. Disruption of the tether by a mutation narrows the outer selectivity filter, realigns Tyr362 to the position seen in other K+ channels, and significantly increases unitary conductance. UCL1684, a mimetic of the bee venom peptide apamin, sits atop the canopy and occludes the opening in the aromatic box. AP14145, an analogue of a therapeutic for atrial fibrillation, binds in the central cavity below the selectivity filter and induces closure of the inner gate. These structures provide a basis for understanding the small unitary conductance and pharmacology of KCa2.x channels.

20 October 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
DIDohyun Im
Dohyun Im
JKJun-ichi Kishikawa
Jun-ichi Kishikawa
YSYuki Shiimura
Yuki Shiimura
HHHiromi Hisano
Hiromi Hisano
AIAkane Ito
Akane Ito
SISo Iwata
So Iwata
Histamine is a biogenic amine that participates in allergic and inflammatory processes by stimulating histamine receptors. The histamine H4 receptor (H4R) is a potential therapeutic target for chronic inflammatory diseases such as asthma and atopic dermatitis. Here, we show the cryo-electron microscopy structures of the H4R-Gq complex bound with an endogenous agonist histamine or the selective agonist imetit bound in the orthosteric binding pocket. The structures demonstrate binding mode of histamine agonists and that the subtype-selective agonist binding causes conformational changes in Phe3447.39, which, in turn, form the “aromatic slot”. The results provide insights into the molecular underpinnings of the agonism of H4R and subtype selectivity of histamine receptors, and show that the H4R structures may be valuable in rational drug design of drugs targeting the H4R.

16 September 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
DIDohyun Im
Dohyun Im
MJMika Jormakka
Mika Jormakka
NJNarinobu Juge
Narinobu Juge
JKJun-ichi Kishikawa
Jun-ichi Kishikawa
TKTakayuki Kato
Takayuki Kato
SISo Iwata
So Iwata
Human vesicular monoamine transporter 2 (VMAT2), a member of the SLC18 family, plays a crucial role in regulating neurotransmitters in the brain by facilitating their uptake and storage within vesicles, preparing them for exocytotic release. Because of its central role in neurotransmitter signalling and neuroprotection, VMAT2 is a target for neurodegenerative diseases and movement disorders, with its inhibitor being used as therapeutics. Despite the importance of VMAT2 in pharmacophysiology, the molecular basis of VMAT2-mediated neurotransmitter transport and its inhibition remains unclear. Here we show the cryo-electron microscopy structure of VMAT2 in the substrate-free state, in complex with the neurotransmitter dopamine, and in complex with the inhibitor tetrabenazine. In addition to these structural determinations, monoamine uptake assays, mutational studies, and pKa value predictions were performed to characterize the dynamic changes in VMAT2 structure. These results provide a structural basis for understanding VMAT2-mediated vesicular transport of neurotransmitters and a platform for modulation of current inhibitor design.

20 January 2025 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
YSYuki Shiimura
Yuki Shiimura
DIDohyun Im
Dohyun Im
RTRyosuke Tany
Ryosuke Tany
HAHidetsugu Asada
Hidetsugu Asada
RKRyoji Kise
Ryoji Kise
IMIkuo Masuho
Ikuo Masuho

20 December 2023 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
TATsuyoshi Araya
Tsuyoshi Araya
YMYuya Matsuba
Yuya Matsuba
HSHarufumi Suzuki
Harufumi Suzuki
TDTomohiro Doura
Tomohiro Doura
NNNipawan Nuemket
Nipawan Nuemket
SISo Iwata
So Iwata
Rational synthetic expansion of photoresponsive ligands is important for photopharmacological studies. Adenosine A2A receptor (A2AR) is stimulated by adenosine and related in Parkinson's disease and other diseases. Here, we report the crystal structure of the A2AR in complex with the novel photoresponsive ligand photoNECA (blue) at 3.34 Å resolution. PhotoNECA (blue) was designed for this structural study and the cell-based assay showed a photoresponsive and receptor selective characteristics of photoNECA (blue) for A2AR. The crystal structure explains the binding mode, photoresponsive mechanism and receptor selectivity of photoNECA (blue). Our study would promote not only the rational design of photoresponsive ligands but also dynamic structural studies of A2AR.

8 January 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
YNYoung-Woo Nam
Young-Woo Nam
ARAlena Ramanishka
Alena Ramanishka
YXYang Xu
Yang Xu
RYRose Marie Haynes Yasuda
Rose Marie Haynes Yasuda
JNJoshua A. Nasburg
Joshua A. Nasburg
MZMiao Zhang
Miao Zhang
Small-conductance (KCa2.2) and intermediate-conductance (KCa3.1) Ca2+-activated K+ channels are gated by a Ca2+-calmodulin dependent mechanism. NS309 potentiates the activity of both KCa2.2 and KCa3.1, while rimtuzalcap selectively activates KCa2.2. Rimtuzalcap has been used in clinical trials for the treatment of spinocerebellar ataxia and essential tremor. We report cryo-electron microscopy structures of NS309-bound KCa2.2 and KCa3.1, in addition to structures of rimtuzalcap-bound KCa2.2 and mutant KCa3.1_R355K. The different conformations of calmodulin and the cytoplasmic HC helices in the two channels underlie the subtype-selectivity of rimtuzalcap for KCa2.2. NS309 binds to pre-existing pockets in both channels, while the bulkier rimtuzalcap binds in an induced-fit pocket in KCa2.2 requiring conformational changes. In KCa2.2, calmodulin’s N-lobes are sufficiently far apart to enable conformational changes to accommodate either NS309 or rimtuzalcap. In KCa3.1, calmodulin’s N-lobes are closer to each other and constrained by KCa3.1’s HC helices, which allows binding of NS309 but not rimtuzalcap. Replacement of arginine-355 in KCa3.1’s HB helix with lysine (KCa3.1_R355K) allows the binding of rimtuzalcap and renders the mutant channel sensitive to rimtuzalcap. These structures provide a framework for structure-based drug design targeting KCa2.2 channels.